The Hospital Anxiety and Depression Scale (HADS) and the 9‐item Patient Health Questionnaire (PHQ‐9) as screening instruments for depression in patients with cancer
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Depression screening in patients with cancer is recommended by major clinical guidelines, although the evidence on individual screening tools is limited for this population. Here, the authors assess and compare the diagnostic accuracy of 2 established screening instruments: the depression modules of the 9‐item Patient Health Questionnaire (PHQ‐9) and the Hospital Anxiety and Depression Scale (HADS‐D), in a representative sample of patients with cancer. METHODS: This multicenter study was conducted with a proportional, stratified, random sample of 2141 patients with cancer across all major tumor sites and treatment settings. The PHQ‐9 and HADS‐D were assessed and compared in terms of diagnostic accuracy and receiver operating characteristic (ROC) curves for Diagnostic and Statistical Manual of Mental Disorders, 4th edition diagnosis of major depressive disorder using the Composite International Diagnostic Interview for Oncology as the criterion standard. RESULTS: The diagnostic accuracy of the PHQ‐9 and HADS‐D was fair for diagnosing major depressive disorder, with areas under the ROC curves of 0.78 (95% confidence interval, 0.76‐0.79) and 0.75 (95% confidence interval, 0.74‐0.77), respectively. The 2 questionnaires did not differ significantly in their areas under the ROC curves (P = .15). The PHQ‐9 with a cutoff score ≥7 had the best screening performance, with a sensitivity of 83% (95% confidence interval, 78%‐89%) and a specificity of 61% (95% confidence interval, 59%‐63%). The American Society of Clinical Oncology guideline screening algorithm had a sensitivity of 44% (95% confidence interval, 36%‐51%) and a specificity of 84% (95% confidence interval, 83%‐85%). CONCLUSIONS: In patients with cancer, the screening performance of both the PHQ‐9 and the HADS‐D was limited compared with a standardized diagnostic interview. Costs and benefits of routinely screening all patients with cancer should be weighed carefully. Cancer 2017;123:4236–4243. © 2017 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856 · cited 2×
“17) 10 40 (32-47) 88 (86-89) 27 (24-31) 15 (11-18) 96 (96-97) 85 (84-86) 0.”
Measuring nominal scale agreement among many raters.
Fleiss, J. L. (1971) · Psychological Bulletin · doi:10.1037/h0031619 · Cited by 8,733 · cited 3×
“17) 10 40 (32-47) 88 (86-89) 27 (24-31) 15 (11-18) 96 (96-97) 85 (84-86) 0.”
BackgroundDiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70002-x · Cited by 2,449 · cited 9×
“8 61 (53-68) 77 (76-79) 38 (34-42) 12 (10-15) 97 (97-98) 76 (75-78) 0.”
InfluentialSelf-citationComparing effect sizes in follow-up studies: ROC Area, Cohen's d, and r.
Rice, M. E., & Harris, G. T. (2005) · Law and Human Behavior · doi:10.1007/s10979-005-6832-7 · Cited by 1,608
Depression and cancer mortality: a meta-analysis
Pinquart, M., & Duberstein, P. R. (2010) · Psychological Medicine · doi:10.1017/s0033291709992285 · Cited by 1,083 · cited 5×
“atopic dermatitis and psoriasis 12 (1)”
BackgroundInfluentialAndersen, B. L., DeRubeis, R. J., Berman, B. S., Gruman, J., Champion, V. L., Massie, M. J., Holland, J. C., Partridge, A. H., Bak, K., Somerfield, M. R., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.4611 · Cited by 735
Four-Week Prevalence of Mental Disorders in Patients With Cancer Across Major Tumor Entities
Mehnert, A., Brähler, E., Faller, H., Härter, M., Keller, M., Schulz, H., Wegscheider, K., Weis, J., Boehncke, A., Hund, B., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.0086 · Cited by 649
Self-citationMitchell, A. J., Meader, N., & Symonds, P. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.01.067 · Cited by 394 · cited 2×
“Hypothyroidism/hyperthyroidism 121 (6)”
Cited by
Comorbid depression in medical diseases
Gold, S. M., Köhler-Forsberg, O., Moss-Morris, R., Mehnert, A., Miranda, J. J., Bullinger, M., Steptoe, A., Whooley, M. A., & Otte, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0200-2 · Cited by 534
Self-citationNaser, A. Y., Dahmash, E. Z., Al‐Rousan, R., Alwafi, H., Alrawashdeh, H. M., Ghoul, I., Abidine, A., Bokhary, M. A., AL‐Hadithi, H. T., Ali, D., et al. (2020) · Brain and Behavior · doi:10.1002/brb3.1730 · Cited by 398
Sun, Y., Fu, Z., Bo, Q., Mao, Z., Ma, X., & Wang, C. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02885-6 · Cited by 343
Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline
Grassi, L., Caruso, R., Riba, M. B., Lloyd-Williams, M., Kissane, D., Rodin, G., McFarland, D., Campos-Ródenas, R., Zachariae, R., Santini, D., et al. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101155 · Cited by 316
Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic
Wang, Y., Duan, Z., Ma, Z., Mao, Y., Li, X., Wilson, A., Qin, H., Ou, J., Peng, K., Zhou, F., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00950-y · Cited by 304
Metadata
- Authors
- Hartung, T. J., Friedrich, M., Johansen, C., Wittchen, H., Faller, H., Koch, U., Brähler, E., Härter, M., Keller, M., Schulz, H., Wegscheider, K., Weis, J., & Mehnert, A.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2017-06-27
- Volume
- 123
- Issue
- 21
- Pages
- 4236-4243
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2725136509
- Cited by
- 155
- References
- 13
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Hospital Anxiety and Depression Scale (HADS) and the 9‐item Patient Health Questionnaire (PHQ‐9) as screening instruments for depression in patients with cancer. https://app.cochat.ai/papers/10.1002/cncr.30846
- The paper
- Hartung, T. J., Friedrich, M., Johansen, C., Wittchen, H., Faller, H., Koch, U., Brähler, E., Härter, M., Keller, M., Schulz, H., Wegscheider, K., Weis, J., & Mehnert, A. (2017). The Hospital Anxiety and Depression Scale (HADS) and the 9‐item Patient Health Questionnaire (PHQ‐9) as screening instruments for depression in patients with cancer. Cancer. https://doi.org/10.1002/cncr.30846
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.